Oh, Hyun Geun
Jung, Minyoung
Jeong, Seon-Yeong
Kim, Jimin
Han, Sang‑Deok
Kim, Hongduk
Lee, Seulki
Lee, Yejin
You, Haedeun
Park, Somi
Kim, Eun A.
Kim, Tae Min http://orcid.org/0000-0003-0015-2701
Kim, Soo
Funding for this research was provided by:
R&D Budget of Brexogen Inc.
Article History
Received: 14 March 2024
Accepted: 27 August 2024
First Online: 11 September 2024
Declarations
:
: All authors performed experiments and analyses involving human materials and data in accordance with the Declaration of Helsinki. The ethics statement of the human cells used in the study follows the policy of each supplier. We confirmed the ethical statements for the use of iPSCs in the website (). Also, ethical approval and the informed consent by the donors for the collection of HFDPCs was confirmed in ‘Certificate of Analysis’ provided by PromoCell Inc. All animal experiments were approved by the Institutional Animal Care and Use Committee of the Seoul National University (Approval date: 16th March 2023; Approval Number: SNU-230116-4-1; Project title: Therapeutic assessment of mesenchymal stem cell-derived extracellular vesicles for atopic dermatitis).
: Not applicable.
: The authors declare that they have no competing interests.